TipRanks
Advertisement
Advertisement
Avacta’s AVA6103 Trial Data Boost Confidence in Next-Gen Pancreatic Cancer Therapy
PremiumCompany AnnouncementsAvacta’s AVA6103 Trial Data Boost Confidence in Next-Gen Pancreatic Cancer Therapy
13d ago
Avacta’s AVA6103 Hits Clinical Proof of Mechanism, Outperforms Enhertu in Preclinical Study
Premium
Company Announcements
Avacta’s AVA6103 Hits Clinical Proof of Mechanism, Outperforms Enhertu in Preclinical Study
22d ago
Avacta strengthens board with new audit chair amid oncology push
Premium
Company Announcements
Avacta strengthens board with new audit chair amid oncology push
24d ago
Avacta Data Underscore Broad Potential of pre|CISION Cancer Platform
PremiumCompany AnnouncementsAvacta Data Underscore Broad Potential of pre|CISION Cancer Platform
3M ago
Avacta Wins FDA Backing for Single Pivotal Trial of AVA6000 in Salivary Gland Cancer
Premium
Company Announcements
Avacta Wins FDA Backing for Single Pivotal Trial of AVA6000 in Salivary Gland Cancer
3M ago
Avacta Wins Strong Shareholder Backing as All AGM Resolutions Pass
Premium
Company Announcements
Avacta Wins Strong Shareholder Backing as All AGM Resolutions Pass
4M ago
Avacta reshapes board leadership as oncology pipeline advances
PremiumCompany AnnouncementsAvacta reshapes board leadership as oncology pipeline advances
4M ago
Avacta publishes 2025 annual report and sets June AGM with online business update
Premium
Company Announcements
Avacta publishes 2025 annual report and sets June AGM with online business update
4M ago
Avacta Earnings Call: Clinical Progress Amid Funding Risks
Premium
Company Announcements
Avacta Earnings Call: Clinical Progress Amid Funding Risks
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―